首页> 外国专利> Cancer Treatment and Cancer Treatment Efficacy Prediction by Blocking and Detecting Protease Inhibitors

Cancer Treatment and Cancer Treatment Efficacy Prediction by Blocking and Detecting Protease Inhibitors

机译:通过阻断和检测蛋白酶抑制剂来预测癌症治疗和癌症治疗的功效

摘要

Disclosed is a method for improving cancer therapy that relies on induction of apoptosis in malignant cells. It has been found that docking of protease inhibitors PAI-1 and TIMP-1 renders malignant cells expressing these inhibitors more sensitive to apoptosis, whereas non-malignant cells do not change their sensitivity to apoptosis induction. It is therefore possible to increase the effect of various anti-cancer treatments in a rational manner and to predict whether or not an apoptosis-inducing cancer treatment will be effective in a patient or not. The invention also provides for methods of identifying agents that inhibit the apoptosis sensitivity modulating effects of protease inhibitors and to methods of identifying anti-cancer compounds that are not dependent on an apoptosis inducing mechanism which can be modulated by protease inhibitors.
机译:公开了一种依赖于诱导恶性细胞凋亡的改善癌症治疗的方法。已经发现蛋白酶抑制剂PAI-1和TIMP-1的对接使表达这些抑制剂的恶性细胞对凋亡更敏感,而非恶性细胞不改变其对凋亡诱导的敏感性。因此,有可能以合理的方式提高各种抗癌治疗的效果,并预测诱导细胞凋亡的癌症治疗对患者是否有效。本发明还提供了鉴定抑制蛋白酶抑制剂的凋亡敏感性调节作用的试剂的方法,以及鉴定不依赖于可以被蛋白酶抑制剂调节的凋亡诱导机理的抗癌化合物的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号